19 reports

Heart Attack Diagnostics Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Heart Attack Diagnostics market including the COVID-19 pandemic implications...

  • Diagnostics
  • Heart Attack
  • APAC
  • Central America

The global drug-eluting stents market reached a value of US$ 7.3 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 10.8 Billion by 2027, exhibiting a CAGR of 6.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Cardiovascular Disease
  • Heart Attack
  • Heart Failure
  • Coating
  • Hospital
  • Implantable Delivery
  • World

Heart Attack Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Heart Attack Diagnostics Market Size, Outlook and Growth Opportunities to 2025: By Test Type (Electrocardiogram (ECG or EKG), Blood tests, and Others) and By Region Heart Attack Diagnostics market outlook to 2025 report...

  • Heart Attack
  • Diagnostics
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

Global Clot Buster Drugs Market, By Type (Fibrin Specific Drugs {Tissue Plasminogen Activator, Reteplase, Tenecteplase, Others} v/s Non-Fibrin Specific Drugs {Urokinase, Streptokinase, Plasminogen Activating Complex}), By Application (Myocardial Infarction, Pulmonary Embolism, Deep Vein Thrombosis, Acute Ischemic Strokes, Others),...

  • Cardiovascular Disease
  • In-Store Retail
  • Compression Therapy
  • Blood Disease
  • Stroke
  • Heart Attack
  • World
  • Mortality Rate
  • Alcohol Excessive Use

The North America Cardiovascular Ultrasound Market would witness market growth of 9.5% CAGR during the forecast period (2021-2027). The growth of the overall market would be propelled by the constant surge in the penetration of preventive medicine and surge in the occurrence of cardiovascular diseases (CVDs). Cardiovascular diseases...

  • Cardiovascular Disease
  • Diagnostics
  • Ambulatory Care
  • Heart Attack
  • Cardiac Monitoring
  • North America
  • United States

Cardiovascular and Soft Tissue Repair Patches Market Size, Share & Trends Analysis Report by Application (Cardiac, Soft Tissue), By Raw Material (ePTFE, Biomaterial), And Segment Forecasts, 2019 - 2025 The global cardiovascular and soft tissue repair patches market size is expected to reach USD 5.71 billion by 2025,...

  • Cardiovascular Disease
  • Digestive System Disorder
  • Heart Attack
  • World
  • North America
  • United States
  • APAC

Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products.The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS...

  • Heart Attack
  • Clinical Trial
  • Analgesic
  • Asthma
  • E-Reader
  • United States
  • Computer Expenditure
  • Employment Income

Anticoagulants Market - Overview Anticoagulants prevent clot formation or enlargement of existing clots in the arteries or veins.Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists, DTIs, and factor Xa inhibitors, are the various anticoagulants available...

  • Cardiovascular Disease
  • Blood Disease
  • Heart Attack
  • Compression Therapy
  • World

KEY FINDINGS The Asia Pacific alternative sweeteners market is evaluated to record a CAGR of 3.85%, over the studied period of 2021 to 2028. The region’s market growth is driven by factors such as, the rising demand for flavored dairy products, the increasing incidence of health-related problems like diabetes, hypertension,...

  • Diabetes
  • Processed Food
  • Public Health
  • Heart Attack
  • Dairy Products
  • Diet Food
  • APAC
  • Disposable Income
  • Mortality Rate

This study covers the world outlook for heart attack diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Heart Attack
  • World
  • Gross Domestic Product
  • Disposable Income

The report entitled “Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025 Edition)” provides an in-depth analysis of the global anticoagulants market with description of market size and growth. The analysis include market share by segment and by products. The report also provides an analysis of injectable...

  • Cardiovascular Disease
  • Blood Disease
  • Healthcare
  • Compression Therapy
  • Heart Attack
  • World
  • Health Expenditure

With ongoing improvements in reading accuracy, it is expected that the non-invasive and minimally invasive technologies will drive growth in the ICU and ER market, while cannibalizing the procedural volume of PAC treatments in the OR. Over the forecast period, the minimally and non-invasive monitoring segments will continue to grow, motivated...

  • Heart Attack
  • Cardiac Monitoring
  • Blood Disease

U.S. Emergency Medical Services (EMS) Products Market Size, Share & Trends Analysis Report By Product, By End-use (Fire Department, Private Transport, Government, Hospital Owned, Volunteer), And Segment Forecasts, 2018 - 2025 The U.S. emergency medical services (EMS) products market is anticipated to reach USD 15.09 billion by 2025...

  • Hospital
  • Healthcare
  • Private Transport
  • Heart Attack
  • United States
  • Health Expenditure

Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs.The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and continuity education departments. Its...

  • Heart Attack
  • Virtual Reality
  • Medical Technology Density

Atherosclerotic heart disease is a heart condition in which plaque piles up in arteries of a patient, which reduces the area for free flow of blood, thereby, causing angina or chest pain. This can eventually turn out to be a heart attack and arrhythmia. With an estimated 18 million population being affected in the US, Atherosclerotic heart...

  • Cardiovascular Disease
  • Angina
  • Heart Attack
  • Therapy
  • Clinical Trial
  • United States

Blood Clotting also known as coagulation is the body’s response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Rising incidences of Heart failure,...

  • Blood Device
  • Cardiovascular Devices
  • Peripheral Vascular Device
  • Healthcare IT
  • Heart Attack
  • Health Services
  • Heart Failure
  • Hemostat
  • Diagnostics
  • Saudi Arabia
  • Brazil
  • United Arab Emirates
  • Argentina
  • South Africa

The market for cardiac output monitoring includes pulmonary artery catheters (PAC), minimally invasive, and non-invasive monitoring devices as well as the sensors associated with each of these modalities. In recent years, less invasive technologies have displaced the PAC, as physicians move towards reliable techniques that reduce the impact...

  • Intensive Care
  • Cardiac Monitoring
  • Drug Delivery
  • Heart Attack
  • United States

Sleep apnea is a common disorder that occurs when a person’s breathing is interrupted during sleep. Sleep apnea is a chronic condition and often largely goes undiagnosed. Sleep apnea can be further differentiated into three types: obstructive sleep apnea, central sleep apnea, and complex/mixed sleep apnea. Obstructive sleep apnea occurs when...

  • Chronic Disease
  • Heart Attack
  • Heart Failure
  • Hypertension
  • Hospital
  • World
  • APAC

Despite the publication of full data from AstraZeneca's PEGASUS-TIMI 54 study this weekend, their remains mixed views as to whether trial results will drive a significant increase in the use of the platelet aggregation inhibitor Brilinta. The PEGASUS study has...

  • Salicylic Acid
  • Pain Relief
  • Cardiovascular Drug
  • Heart Attack
  • Cardiology
  • United States
  • Generics Use